Loading…

Cost burden of inappropriate peri-operative antibacterial use in a teaching tertiary-care rural hospital in India

Background The most common indication for antibacterial chemoprophylaxis is to reduce the risk of surgical infection. Appropriate use of antibacterial is effective in the prevention of surgical site infections, but inappropriate prescribing and excessive use of such drugs increases the cost of thera...

Full description

Saved in:
Bibliographic Details
Published in:Drugs & therapy perspectives : for rational drug selection and use 2013-08, Vol.29 (8), p.247-252
Main Authors: Shah, Amit M., Shah, Rima B., Gajjar, Bharat M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The most common indication for antibacterial chemoprophylaxis is to reduce the risk of surgical infection. Appropriate use of antibacterial is effective in the prevention of surgical site infections, but inappropriate prescribing and excessive use of such drugs increases the cost of therapy, as well as the risk of antibacterial resistance. Objective To study the cost burden of inappropriate peri-operative antibacterial use in a teaching tertiary-care rural hospital in India. Study design A prospective observational study of 200 patients from four surgical departments was conducted from February to October 2010. Data were analysed for class of surgical wound, and the use, appropriateness and cost burden of peri-operative antibacterial therapy. Results The majority of patients (45.5 %) had class II surgical wounds followed by Class I (26 %), Class III (17.5 %) and Class IV (11 %). In 143 patients with class I or II surgical wounds, inappropriate peri-operative antibacterials were prescribed in 119 (83.2 %) patients. Among these 119 patients, the choice of antibacterial was inappropriate in 76.5 % of patients, the duration of treatment was inappropriate in all patients, and the mean antibacterial cost was Indian rupee 541.29, which was significantly ( p  
ISSN:1172-0360
1179-1977
DOI:10.1007/s40267-013-0051-y